Felice Gragnano

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Alcohol Consumption

Antiplatelet Therapy

St Segment Elevation Myocardial Infarction

Top Venues

Journal of clinical medicine

European heart journal. Cardiovascular pharmacotherapy

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Felice Gragnano, Vincenzo De Sio, Arturo Cesaro, Paolo Calabrò
Ticagrelor monotherapy after acute coronary syndrome: lessons from the ULTIMATE-DAPT trial. Future cardiology (2024)
Felice Gragnano, Antonio Capolongo, Mattia Galli, Paolo Calabrò
OCEANIC-AF trial: factor XI inhibitors revolution in atrial fibrillation is on hold. European heart journal. Cardiovascular pharmacotherapy (2024)
Arturo Cesaro, Vincenzo Acerbo, Erica Vetrano, Giovanni Signore, Gianmaria Scherillo, Francesco Paolo Rotolo, Gianantonio De Michele, Francesco Scialla, Giuseppe Raucci, Domenico Panico, Felice Gragnano, Elisabetta Moscarella, Raffaele Galiero, Alfredo Caturano, Roberto Ruggiero, Ferdinando Carlo Sasso, Paolo Calabrò
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice. International journal of molecular sciences 24 (9) (2023)
Felice Gragnano, Francesco Pelliccia, Natale Guarnaccia, Giampaolo Niccoli, Salvatore De Rosa, Raffaele Piccolo, Elisabetta Moscarella, Enrico Fabris, Rocco Antonio Montone, Arturo Cesaro, Italo Porto, Ciro Indolfi, Gianfranco Sinagra, Pasquale Perrone Filardi, Giuseppe Andò, Paolo Calabrò, null null
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective. Journal of clinical medicine 12 (8) (2023)
Felice Gragnano, Antonio Capolongo, Paolo Calabrò
P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift? Current vascular pharmacology (2023)
Felice Gragnano, Francesco Pelliccia, Natale Guarnaccia, Giampaolo Niccoli, Salvatore De Rosa, Raffaele Piccolo, Elisabetta Moscarella, Enrico Fabris, Rocco Antonio Montone, Arturo Cesaro, Italo Porto, Ciro Indolfi, Gianfranco Sinagra, Pasquale Perrone Filardi, Giuseppe Andò, Paolo Calabrò, null null
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective. Journal of clinical medicine 12 (8) (2023)
Felice Gragnano, Paolo Calabrò, Mattia Galli
What's new in pharmacotherapy at ESC Congress 2023? European heart journal. Cardiovascular pharmacotherapy (2023)
Felice Gragnano, Vincenzo De Sio, Paolo Calabrò
The year in cardiovascular pharmacotherapy 2022: landmark evidence at a glance. European heart journal. Cardiovascular pharmacotherapy (2023)
Andrea Vergara, De Felice Marco, Arturo Cesaro, Felice Gragnano, Ivana Pariggiano, Enrica Golia, Antonio De Pasquale, Ettore Blasi, Fabio Fimiani, Emanuele Monda, Giuseppe Limongelli, Paolo Calabrò
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go. Angiology (2023)
Felice Gragnano, Antonio Capolongo, Antonio Micari, Renato Francesco Maria Scalise, Victoria Garcia-Ruiz, Vincenzo De Sio, Fabrizia Terracciano, Arturo Cesaro, Elisabetta Moscarella, Silvio Coletta, Pasquale Raucci, Fabio Fimiani, Leonardo De Luca, Giuseppe Gargiulo, Giuseppe Andò, Paolo Calabrò
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Journal of clinical medicine 13 (1) (2023)
Felice Gragnano, Antonio Capolongo, Antonio Micari, Renato Francesco Maria Scalise, Victoria Garcia-Ruiz, Vincenzo De Sio, Fabrizia Terracciano, Arturo Cesaro, Elisabetta Moscarella, Silvio Coletta, Pasquale Raucci, Fabio Fimiani, Leonardo De Luca, Giuseppe Gargiulo, Giuseppe Andò, Paolo Calabrò
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Journal of clinical medicine 13 (1) (2023)
Riccardo Rinaldi, Giuseppe Princi, Giulia La Vecchia, Alice Bonanni, Giovanni Alfonso Chiariello, Alessandro Candreva, Felice Gragnano, Paolo Calabrò, Filippo Crea, Rocco Antonio Montone
MINOCA Associated with a Myocardial Bridge: Pathogenesis, Diagnosis and Treatment. Journal of clinical medicine 12 (11) (2023)
Felice Gragnano, Paolo Calabrò
The Latest News from ACC 2023. European heart journal. Cardiovascular pharmacotherapy (2023)
Felice Gragnano, Fabrizia Terracciano, Paolo Calabrò
SGLT2 Inhibitors as the Backbone of Therapy for Cardiovascular and Renal Protection. Journal of cardiovascular translational research (2023)
Felice Gragnano, Francesco Pelliccia, Natale Guarnaccia, Giampaolo Niccoli, Salvatore De Rosa, Raffaele Piccolo, Elisabetta Moscarella, Enrico Fabris, Rocco Antonio Montone, Arturo Cesaro, Italo Porto, Ciro Indolfi, Gianfranco Sinagra, Pasquale Perrone Filardi, Giuseppe Andò, Paolo Calabrò, null null
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective. Journal of clinical medicine 12 (8) (2023)
Felice Gragnano, Vincenzo De Sio, Paolo Calabrò
FLOW trial stopped early due to evidence of renal protection with semaglutide. European heart journal. Cardiovascular pharmacotherapy (2023)
Felice Gragnano, Vincenzo De Sio, Paolo Calabrò
What is new in the 2023 AHA/ACC Multisociety guideline on Chronic coronary Disease? European heart journal. Cardiovascular pharmacotherapy (2023)
Arturo Cesaro, Vincenzo Acerbo, Erica Vetrano, Giovanni Signore, Gianmaria Scherillo, Francesco Paolo Rotolo, Gianantonio De Michele, Francesco Scialla, Giuseppe Raucci, Domenico Panico, Felice Gragnano, Elisabetta Moscarella, Raffaele Galiero, Alfredo Caturano, Roberto Ruggiero, Ferdinando Carlo Sasso, Paolo Calabrò
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice. International journal of molecular sciences 24 (9) (2023)
Felice Gragnano, Francesco Pelliccia, Natale Guarnaccia, Giampaolo Niccoli, Salvatore De Rosa, Raffaele Piccolo, Elisabetta Moscarella, Enrico Fabris, Rocco Antonio Montone, Arturo Cesaro, Italo Porto, Ciro Indolfi, Gianfranco Sinagra, Pasquale Perrone Filardi, Giuseppe Andò, Paolo Calabrò, null null
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective. Journal of clinical medicine 12 (8) (2023)
Giuseppe Patti, Vito Maurizio Parato, Ilaria Cavallari, Paolo Calabrò, Vincenzo Russo, Giulia Renda, Felice Gragnano, Vittorio Pengo, Antonio D'Onofrio, Massimo Grimaldi, Raffaele De Caterina
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation. Journal of clinical medicine 11 (7) (2022)
Felice Gragnano, Antonio Capolongo, Fabrizia Terracciano, Giuseppe Gargiulo, Vincenzo De Sio, Arturo Cesaro, Elisabetta Moscarella, Giuseppe Patti, Italo Porto, Giovanni Esposito, Dominick J Angiolillo, Paolo Calabrò
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice. Journal of clinical medicine 11 (21) (2022)
Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, Dik Heg, Kurt Schmidlin, Christian Hamm, Phillippe Gabriel Steg, Giuseppe Gargiulo, Eugene P McFadden, Yoshinobu Onuma, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Sergio Leonardi, Aleksander Zurakowski, Alessio Arrivi, Robert-Jan M van Geuns, Kurt Huber, Ton Slagboom, Paolo Calabrò, Patrick W J C Serruys, Peter Jüni, Marco Valgimigli, Stephan Windecker, null null
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial. Journal of the American Heart Association 11 (10) (2022)
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Elisabetta Moscarella, Felice Gragnano, Teresa Salvatore, Luca Rinaldi, Paolo Calabrò, Ferdinando Carlo Sasso
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects. International journal of molecular sciences 22 (11) (2021)
Mariarita Brancaccio, Cristina Mennitti, Arturo Cesaro, Fabio Fimiani, Elisabetta Moscarella, Martina Caiazza, Felice Gragnano, Annaluisa Ranieri, Giovanni D'Alicandro, Nadia Tinto, Cristina Mazzaccara, Barbara Lombardo, Raffaela Pero, Giuseppe Limongelli, Giulia Frisso, Paolo Calabrò, Olga Scudiero
Dietary Thiols: A Potential Supporting Strategy against Oxidative Stress in Heart Failure and Muscular Damage during Sports Activity. International journal of environmental research and public health 17 (24) (2020)
Paolo Calabrò, Felice Gragnano, Marco Di Maio, Giuseppe Patti, Emilia Antonucci, Plinio Cirillo, Paolo Gresele, Gualtiero Palareti, Vittorio Pengo, Pasquale Pignatelli, Mauro Pennacchi, Antonino Granatelli, Stefano De Servi, Leonardo De Luca, Rossella Marcucci, null null
Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry. Angiology 69 (9) (2018)
Felice Gragnano, Mario Crisci, Maurizio Cappelli Bigazzi, Renatomaria Bianchi, Simona Sperlongano, Francesco Natale, Fabio Fimiani, Claudia Concilio, Arturo Cesaro, Ivana Pariggiano, Vincenzo Diana, Giuseppe Limongelli, Plinio Cirillo, Mariagiovanna Russo, Enrica Golia, Paolo Calabrò
Von Willebrand Factor as a Novel Player in Valvular Heart Disease: From Bench to Valve Replacement. Angiology 69 (2) (2017)
Felice Gragnano, Simona Sperlongano, Enrica Golia, Francesco Natale, Renatomaria Bianchi, Mario Crisci, Fabio Fimiani, Ivana Pariggiano, Vincenzo Diana, Andreina Carbone, Arturo Cesaro, Claudia Concilio, Giuseppe Limongelli, Mariagiovanna Russo, Paolo Calabrò
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators of inflammation 2017 (2017)